Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

NOTE: It is important to note that this protocol uses replication-deficient lentiviruses. Perform viral handling only after appropriate lab safety training. Bleach all items and surfaces that come in contact with live viruses for a minimum of 10 min after handling. Use a disposable lab coat and face/eye protection, as well as double gloves, at all times. Perform virus work in biosafety level 2+ labs with viral certification. Dedicate tissue culture hoods and incubators to viral work.

1. Vector Design and Generation

NOTE: The best way to identify gRNA sequences is to use online design tools (e.g., http://crispr-era.stanford.edu) (Supplemental Figure 1: gRNA design). For the accompanying representative experiment, a company designed and created the gRNA vectors used in the representative experiment. The dCas9 plasmid was also purchased online.

1. The gRNA sequence is located upstream of the nucleotide sequence “NGG”, where “N” is any nucleotide, which also is within 100 base-pairs of the transcriptional start site. Search genetic databases such as BLAT (https://genome.ucsc.edu/cgi-bin/hgBlat?command=start) for the gRNA sequence, to make sure there are no other sites in the genome with similar sequences (Supplemental Figure 2: BLAT). This will ensure that the gRNA sequence is unique to the gene of interest (GOI).
2. Store the gRNA and dCas9 plasmids, which come as bacterial stubs, at 4 °C. Streak out Escherichia coli on a Luria broth (LB) agar plate with ampicillin (Supplemental Table 1) and grow the bacteria overnight at 37 °C.
3. Pick a colony and grow the bacteria in 5 mL of LB with ampicillin (Supplemental Table 1) overnight, vigorously shaking the plate in a 37 °C incubator. The next day, add 2 mL of bacteria to 200 mL of LB with ampicillin grow in a 2 L flask, vigorously shaking the flask overnight in a 37 °C incubator.
4. Spin down the bacteria at 3,724 x g for 20 min. Remove the media and place the tube containing the bacteria on ice.
5. Purify bacterial DNA using a plasmid purification kit per the manufacturer’s protocol.
   NOTE: The plasmid purification kits contain proprietary resuspension buffer, lysis buffer, wash buffer, equilibration buffer, and elution buffer.
   1. Add 10 mL of resuspension buffer from the kit to the bacteria and pipet the bacteria into the solution. Then, add 10 mL of lysis buffer from the kit to the resuspended bacteria and mix them by inverting the tube. Wait 5 min to lyse the bacteria; then, add 10 mL of ice-cold neutralization buffer from the kit to the lysed bacteria and mix them by inverting the tube.
   2. Equilibrate the DNA column from the kit with 10 mL of equilibration buffer for 5 min. Pour the samples into the DNA column filter and let the solution pass through the filter.
   3. Wash the samples 2x with 30 mL of wash buffer and, then, elute the DNA with 30 mL of elution buffer in a 15 mL conical tube. Slowly layer 10.5 mL of isopropanol at room temperature onto the eluted DNA, invert the tube, and immediately spin it at 16,200 x g for 30 min at 4 °C.
   4. Remove the supernatant and add 1 mL of 70% ethanol to the DNA pellet. Resuspend the pellet by flicking the tube. Spin it at 16,200 x g for 10 min at 4 °C and use a 200 μL pipet tip to remove most of the ethanol. Air-dry the pellet for 5 min and resuspend it in 200 μL of water, and store the DNA at -20 °C. The expected concentration will be >1 μg/μL.

2. Virus Generation and Particle Count

1. When ready to create the dCAS9-containing lentivirus, coat 100 mm tissue culture dishes with 5 mL of 0.01% poly-L-lysine (Supplemental Table 1). Remove the excess liquid thoroughly from the plates and let them air-dry for a few minutes in a biosafety cabinet.
2. Plate 5 x 10⁶ HEK 293T cells per dish in 10 mL of complete Dulbecco’s modified Eagle’s medium (DMEM) (Supplemental Table 1) and incubate them overnight at 37 °C with 5% CO₂. The next day, remove the medium from the HEK 293T dishes and add 10 mL of complete DMEM.
3. Mix 6.5 μg of plasmid pMDLg/pRRE containing the gag/pol (components of the virus), 3.5 μg of the plasmid pMDG2.G containing the VSV-G (a component of the virus), 2.5 µg of the plasmid pRSV-Rev containing Rev (a component of the virus), 10 μg of an long terminal repeat (LTR)-containing gRNA vector or an LTR-containing dCas9 vector and add water to a total volume of 450 μL. Filter the mixture through a 0.2 µm filter tip attached to a syringe.
4. Add 50 µL of 2.5 M CaCl₂ (Supplemental Table 1) to each transfection sample of DNA and mix gently. Filter the calcium/DNA mixture through a 0.2 µm filter tip attached to a syringe. Pipet 500 µL of 2x HBS (Supplemental Table 1) into a 5 mL polystyrene tube. Add the 500 µL DNA/CaCl₂ mix dropwise and gently vortex. Incubate at room temperature for 3 min.
5. Slowly add 1 mL of the DNA/CaCl₂/HBS suspension to each dish. Immediately swirl the dishes to distribute the contents evenly. Incubate each dish overnight in a 5% CO₂ incubator at 37 °C.
6. On day 3, slowly remove and discard the media from the dishes. Carefully wash the cells 1x with phosphate-buffered saline (PBS). Add 6 mL of complete DMEM supplemented with 20 mM HEPES and 10 mM sodium butyrate. Incubate the cells for 5–6 h in a 5% CO₂ incubator at 37 °C.
7. Wash the cells 1x with PBS and add 5 mL of complete DMEM with 20 mM HEPES to the HEK 293T cells. Incubate for 12 h overnight in a 5% CO₂ incubator at 37 °C.
8. On day 4, collect the HEK 293T cell supernatants and filter the supernatant. Freeze 1 mL aliquots at -80 °C.
9. When ready to use the virus, thaw an aliquot of the viral particle containing conditioned media (stored as described in step 2.8) on ice. Bring all reagents to room temperature.
10. Use a p24 Enzyme-Linked Immunosorbent Assay (ELISA) kit to quantify the number of viral particles per milliliter.
    1. Dilute the wash concentrate from the kit by adding 19 parts of distilled deionized water. Dilute the positive control from the kit to 200 ng/mL, using RMPI 1640 as the diluent, and make the dilutions for standard curve in 1.5 mL tubes according to the p24 ELISA dilution table (Supplemental Table 2).
    2. Add 20 μL of 5% Triton X-100 to all wells except the substrate blank. Add 200 μL of RPMI 1640 to the negative control wells. Add 200 μL of each standard (in duplicate) to the designated wells.
    3. Using a spectrophotometer, measure the concentration of the virus within the samples, using a standard curve. Start the sample dilution at 1:1,000 and modify the volume as necessary in order to be within the range of the standard curve. Dilute the samples with Triton X-100 to a final concentration of 0.5% and add 200 μL of each sample in RPMI 1640 to designated wells. Seal the plate and incubate it for 2 h at 37 °C.
    4. Wash the plate 6x with 300 μL of 1x wash buffer per well. Remove any excess fluid by inverting the plate and tapping it on a paper towel. Add 100 μL of detector antibody from the kit to all wells except the substrate blank. Seal the plate and incubate it for 1 h at 37 °C. Wash the plate and, then, remove any excess fluid by inverting the plate and tapping it on a paper towel.
    5. In order to measure the detector antibody, prepare streptavidin-horseradish peroxidase (SA-HRP) within 15 min of use. Dilute the SA-HRP at 1:100 with SA-HRP diluent. Mix the diluted SA-HRP thoroughly and add 100 μL to all wells except the blank. Seal and incubate the plate for 30 min at room temperature.
    6. Wash the plate with 1x wash buffer and tap away any excess liquid as in step 2.10.4. Use ortho-phenylenediamine (OPD) substrate solution, which provides the peroxidase the necessary substrates to produce chemiluminescence, within 15 min of preparation. Use one OPD tablet to 11 mL of substrate diluent for each plate.
    7. Vortex the OPD solution vigorously to dissolve it completely and protect it from light. Add 100 μL of OPD substrate solution to all wells, including the blank. Using a spectrophotometer, read absorbance at 450 nm immediately, repeat this 10x at 1 s intervals, and take the average measurement.

3. dCas9-VP64 Transduction

1. Culture Jurkat T cells in complete DMEM in a T75 flask with a density of 2 x 10⁶ cells in 15 mL of media. Culture the cells in a 37 °C incubator with 5% CO₂.
2. Spin down the cells for 5 min at 233 x g and, then, resuspend them in 10 mL of reduced serum media. Count the cells with a hemocytometer or an automated cell counter.
3. Resuspend and plate 1 x 10⁶ Jurkat cells in 5 mL of reduced serum media with polybrene (Supplemental Table 1) in a T75 flask. Add HEK 293T-conditioned media containing 1 x 10⁶ dCas9-containing viral particles. The number of viral particles can be calculated roughly from the p24 ELISA because 1 μg/mL p24 equals 1 x 10⁷ viral particles. Put the flasks in 37 °C incubator with 5% CO₂.

4. Selection and Clone Creation

1. Three days post-infection, spin down the cells at 233 x g for 5 min and resuspend them in 10 mL of complete DMEM with puromycin (Supplemental Table 1). Plate the cells in T75 flasks and culture them at 37 °C with 5% CO₂. Every third day, for a period of 9 days, spin down the cells at 233 x g for 5 min and replace the media with complete DMEM with puromycin.
2. Count the cells using a hemocytometer or an automated cell counter. On a 96-well plate treated with tissue culture, plate 10,000 cells in 100 μL of complete DMEM with puromycin in the first well and serially dilute 1:1 the contents of the following wells with complete DMEM with puromycin. Perform 24 dilutions and repeat this 4x per plate in order to ensure that there is an adequate number of cells per well. Incubate the cells at 37 °C with 5% CO₂.
3. Expand clonal cells into two 24-well plates, then into a 6-well plate, and eventually into a T75 flask. In order to focus on three of the clones, plate 2 x 10⁶ cells per well of a 6-well plate for three of the clones. Plate the other three wells with nontransduced Jurkat cells as controls. Put the cells in a cell culture incubator overnight.
4. For RNA extraction, use a commercially available RNA isolation kit. Spin down the cells at 233 x g for 5 min at room temperature and remove the media. Use a 1 mL pipet tip to resuspend the cells in 350 μL of lysis buffer. Add 350 μL of 70% ethanol to the lysed cells, mix thoroughly with a 1 mL pipet, and transfer the sample to the RNA column.
5. Spin the lysates at 10,000 x g for 1 min, remove the flow-through, and add 700 μL of low-stringency wash buffer from the kit to the column. Spin the lysates at 10,000 x g for 1 min, remove the flow-through, and add 80 µL of DNase I solution from the kit to the column; let the samples incubate for 15 min at room temperature.
6. Spin the lysates at 10,000 x g for 1 min, remove the flow-through, and add 700 µL of high-stringency wash buffer from the kit to the column. Spin the lysates at 10,000 x g for 1 min, remove the flow-through, and add 700 µL of low-stringency wash buffer to the column.
7. Remove the column from the collection tube and transfer it to a new collection tube. Spin the lysates at 10,000 x g for 1 min and, then, transfer the RNA column to a 1.5 mL tube. Add 50 µL of water to the column and spin at 10,000 x g for 1 min.
8. Use a spectrophotometer to quantify the concentration of RNA. Expect the concentration to be between 100–500 ng/µL, with a 260/280 absorbance between 1.9–2.1. Store the RNA at -80 °C.
9. In 250 µL tubes, add 1 µg of RNA, 4 µL of complementary DNA (cDNA) synthesis buffer, 1 µL of reverse transcriptase, and water to a final volume of 20 µL. Include no reverse transcriptase controls. In a thermal cycler, synthesize cDNA at 42 °C for 30 min and at 95 °C for 5 min to inactivate the reverse transcriptase. Dilute the cDNA with 60 µL of water after the synthesis.
10. Prepare polymerase chain reactions (PCRs) containing 5 µL of SYBR green, 4 µL of cDNA, 0.5 µL of forward primer (10 µM), and 0.5 µL of reverse primer (10 µM). Run the PCR as follows: step 1 = 95 °C for 3 min, step 2 = 95 °C for 10 s, step 3 = 60 °C for 10 s, and then, repeat steps 2 and 3 for 30x.
    NOTE: The sequence for the dCas9 forward primer is 5'-TCGCCACAGCATAAAGAAGA and the sequence for the dCas9 reverse primer is 5'-CTTTTCATGGTACGCCACCT. The forward primer for Hypoxanthine Phosphoribosyltransferase 1 (HPRT1) is 5'-GACCAGTCAACAGGGGACAT and the reverse primer is 5'-GCTTGCGACCTTGACCATCT.

5. gRNA Transduction, Selection, Clone Creation, and Screening

1. Retransduce the validated Jurkat-dCas9 cells with gRNA-containing viruses as outlined in section 3. Select cells in DMEM with hygromycin (Supplemental Table 1) for 10 days. Spin down the cells and change the media every 3 days.
2. Perform a serial dilution of cells (as described in step 4.2) and expand individual colonies (as described in step 4.3). Purify RNA from the colonies exactly as described in step 4.5 and perform cDNA synthesis as described in step 4.9. Perform real-time PCR against the GOI and HPRT1 or an appropriate housekeeping gene, similarly to the PCR described in step 4.10, except in this case, image the wells each cycle after step 3.
3. Use the comparative cycle threshold (Ct) method to determine fold change in the GOI⁸. Briefly, use the following equation to calculate relative transcript levels (RTLs): 2^{-(average Ct of GOI – average Ct of housekeeping gene)}. Then, calculate the average RTL of the controls and divide all RTL values by the average control RTL to generate a fold change compared to the control samples.